FindTrial
Sign In

Artesunate Suppositories

DRUG2 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University

Conditions

AIN2/3Alternative TreatmentAnal DysplasiaArtesunateCervical Intraepithelial Neoplasia Grade 2/3HPV-Related Anal Intraepithelial NeoplasiaHigh-risk HPV (Any Strain)Human Papilloma Virus

Phase 1

Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
CompletedNCT02354534
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsCervical Intraepithelial Neoplasia Grade 2/3, High-risk HPV (Any Strain)
Start: 2015-02-28End: 2018-11-06Updated: 2021-04-28
Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
CompletedNCT03100045
Johns Hopkins UniversityAIN2/3, Alternative Treatment, Anal Dysplasia +4
Start: 2017-04-20End: 2021-10-06Updated: 2021-11-03